Pathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's Disease

Brain Pathology - Tập 26 Số 4 - Trang 533-541 - 2016
J. Scott Miners1, Jennifer C Palmer1, Seth Love1
1Dementia Research Group School of Clinical Sciences, Institute of Clinical Neurosciences, University of Bristol Bristol UK

Tóm tắt

AbstractThe earliest decline in cerebral perfusion in Alzheimer's disease (AD) is in the medial parietal cortex (precuneus). We have analyzed precuneus in post‐mortem tissue from 70 AD and 37 control brains to explore the pathophysiology of the hypoperfusion: the contribution of arteriolosclerotic small vessel disease (SVD) and cerebral amyloid angiopathy (CAA), and of the vasoconstrictors endothelin‐1 (EDN1) and angiotensin II (Ang II), and the association with Aβ. The myelin‐associated glycoprotein:proteolipid protein‐1 ratio (MAG:PLP1) was used as an indicator of oxygenation of the precuneus prior to death. MAG:PLP1 was reduced ∼50% in early AD (Braak stage III–IV). Although MAG:PLP1 remained low in advanced AD (stage V–VI), the reduction was less pronounced, possibly reflecting falling oxygen demand. Reduction in cortical MAG:PLP1 correlated with elevation in vascular endothelial growth factor (VEGF), another marker of hypoperfusion. Cortical MAG:PLP1 declined nonsignificantly with increasing SVD and CAA, but significantly with the concentration of EDN1, which was elevated approximately 75% in AD. In contrast, with reduction in cortical MAG:PLP1, Ang II level and angiotensin‐converting enzyme (ACE) activity declined, showing a normal physiological response to hypoperfusion. MAG:PLP1 was reduced in the parietal white matter (WM) in AD but here the decline correlated positively (ie, physiologically) with WM EDN1. However, the decline of MAG:PLP1 in the WM was associated with increasing cortical EDN1 and perhaps reflected vasoconstriction of perforating arterioles, which traverse the cortex to perfuse the WM. EDN1 in the cortex correlated highly significantly with both soluble and insoluble Aβ42, shown previously to upregulate neuronal endothelin‐converting enzyme‐2 (ECE2), but not with Aβ40. Our findings demonstrate reduced oxygenation of the precuneus in early AD and suggest that elevated EDN1, resulting from Aβ42‐mediated upregulation of ECE2, is a contributor.

Từ khóa


Tài liệu tham khảo

10.1111/nan.12212

10.1038/sj.jcbfm.9600570

10.1093/brain/awu040

10.1038/jcbfm.2013.46

10.3233/JAD-2012-120658

10.1073/pnas.1317918110

10.1148/radiol.12120928

10.1007/s00401-006-0127-z

10.1016/0278-5846(86)90009-6

Brun A, 1990, Subcortical pathology of Alzheimer's disease, Adv Neurol, 51, 73

10.1046/j.1365-2990.2003.00457.x

Chui HC, 2012, Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence‐based review, Alzheimers Res Ther, 4

10.1148/radiol.2503080751

10.2174/1567205010666131119234845

10.1016/j.neurobiolaging.2005.02.012

10.1212/WNL.46.6.1592

10.1159/000051183

10.1136/jnnp.49.11.1221

10.1074/jbc.M407358200

10.1111/acel.12045

10.1007/s00401-011-0801-7

10.1111/bpa.12159

10.1001/jamaneurol.2014.186

10.1038/nrn1387

Jochemsen HM, 2015, Angiotensin‐converting enzyme in cerebrospinal fluid and risk of brain atrophy, J Alzheimers Dis, 44, 153, 10.3233/JAD-131496

10.1016/S0197-4580(00)00125-1

10.1001/jamaneurol.2014.754

10.1001/archneurol.2010.30

10.1097/00001756-200308060-00027

10.1007/BF02988596

10.1111/j.1365-2990.2007.00885.x

Miners JS, 2014, Differential changes in Aβ42 and Aβ40 with age, J Alzheimers Dis, 40, 727, 10.3233/JAD-132339

10.3389/fnagi.2014.00238

Miners JS, 2010, ACE variants and association with brain Aβ levels in Alzheimer's disease, Am J Transl Res, 3, 73

Miners S, 2009, Angiotensin‐converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes, Am J Transl Res, 1, 163

10.1111/bpa.12130

10.1038/srep06446

10.1007/s00401-011-0910-3

10.1152/ajpheart.00022.2002

10.1006/nbdi.2001.0460

10.1152/ajpheart.2001.281.6.H2417

10.1212/WNL.47.1.190

10.1074/jbc.M112.422964

10.1016/j.phrs.2010.12.008

10.2353/ajpath.2009.081054

10.3233/JAD-2012-111760

10.1111/j.1365-2990.2010.01084.x

Palmer JC, 2013, Endothelin‐converting enzyme‐1 activity, endothelin‐1 production, and free radical‐dependent vasoconstriction in Alzheimer's disease, J Alzheimers Dis, 36, 577, 10.3233/JAD-130383

10.1161/STROKEAHA.114.005179

10.1212/01.wnl.0000435291.49598.54

10.1074/jbc.272.10.6641

10.1002/ana.20493

10.1016/S0022-510X(02)00114-4

10.1093/brain/awm156

10.1186/s13195-014-0077-y

10.1093/brain/awv025

10.1111/j.1750-3639.2010.00374.x

10.1111/j.1750-3639.2009.00321.x

10.1111/bpa.12218

10.1111/j.1750-3639.2008.00133.x

10.1371/journal.pone.0028263

Thông tin
Thông tin xuất bản

Brain Pathology

Tập 26 Số 4

533-541

Thông tin tác giả